An analytical quality by design-guided method development for the quantification of N-nitroso-fluoxetine to support mitigation strategies for a fluoxetine drug product.

Zhang Y, Sacré PY, Streel B, Ziemons E, Hubert P, Hubert C

Open source

DOI
10.1016/j.jpba.2026.117692
Published
2027 Jan 1
Container
Journal of pharmaceutical and biomedical analysis
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jpba.2026.117692,
  title = {An analytical quality by design-guided method development for the quantification of N-nitroso-fluoxetine to support mitigation strategies for a fluoxetine drug product.},
  author = {Zhang Y and Sacré PY and Streel B and Ziemons E and Hubert P and Hubert C},
  year = {2027},
  journal = {Journal of pharmaceutical and biomedical analysis},
  doi = {10.1016/j.jpba.2026.117692},
  url = {https://doi.org/10.1016/j.jpba.2026.117692}
}

RIS

TY  - JOUR
TI  - An analytical quality by design-guided method development for the quantification of N-nitroso-fluoxetine to support mitigation strategies for a fluoxetine drug product.
AU  - Zhang Y
AU  - Sacré PY
AU  - Streel B
AU  - Ziemons E
AU  - Hubert P
AU  - Hubert C
PY  - 2027
JO  - Journal of pharmaceutical and biomedical analysis
DO  - 10.1016/j.jpba.2026.117692
UR  - https://doi.org/10.1016/j.jpba.2026.117692
ER  - 

APA

Y, Z., PY, S., B, S., E, Z., P, H., & C, H. (2027). An analytical quality by design-guided method development for the quantification of N-nitroso-fluoxetine to support mitigation strategies for a fluoxetine drug product.. Journal of pharmaceutical and biomedical analysis. https://doi.org/10.1016/j.jpba.2026.117692

Source records